Metal-carbenicillin framework-based nanoantibiotics with enhanced penetration and highly efficient inhibition of MRSA

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Infectious Diseases

Background:

• Methicillin-resistant Staphylococcus aureus (MRSA) infections pose a significant therapeutic challenge due to antibiotic resistance mechanisms.
• Antibiotic degradation by enzymes like β-lactamases and poor biofilm penetration limit treatment efficacy.
• Nanoparticle-based drug delivery offers a promising strategy to enhance antibiotic performance against resistant bacteria.

Purpose of the Study:

• To develop a novel nanoantibiotic system for co-delivery of β-lactam antibiotics and β-lactamase inhibitors.
• To overcome MRSA infections by improving biofilm penetration and combating enzymatic resistance.
• To create a stable and effective nanocarrier for synergistic drug release at infection sites.

Main Methods:

• Construction of nanoantibiotics using mesoporous silica nanoparticles (MSN) coated with a metal-carbenicillin framework.
• Carbenicillin (a β-lactam antibiotic) coordinated with Fe³⁺ to form the framework, blocking MSN pores.
• Loading of β-lactamase inhibitors into the MSN for co-delivery with the antibiotic.
• Evaluation of nanoantibiotic stability, drug release kinetics, biofilm penetration, and efficacy against MRSA in vitro and in vivo.

Main Results:

• The developed nanoantibiotics demonstrated stability under physiological conditions.
• Synchronous release of carbenicillin and β-lactamase inhibitors was achieved at the infection site.
• Enhanced penetration depth into bacterial biofilms was observed compared to conventional antibiotics.
• Significant inhibition of MRSA growth and biofilm formation was confirmed in both in vitro and in vivo models.

Conclusions:

• The metal-carbenicillin framework-coated MSN system provides an effective platform for co-delivering antibiotics and inhibitors.
• This nanoantibiotic approach successfully overcomes key MRSA resistance mechanisms, including enzymatic degradation and poor biofilm penetration.
• The findings suggest a promising therapeutic strategy for treating challenging MRSA infections.